sr 95531 has been researched along with pnu-282987 in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (pnu-282987) | Trials (pnu-282987) | Recent Studies (post-2010) (pnu-282987) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 146 | 0 | 123 |
| Protein | Taxonomy | sr 95531 (IC50) | pnu-282987 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.541 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.541 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Li, G; Wu, J; Yang, B; Zhang, R; Zhang, S; Zhou, X | 1 |
1 other study(ies) available for sr 95531 and pnu-282987
| Article | Year |
|---|---|
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzamides; Bridged Bicyclo Compounds; Cell Survival; Chronic Disease; Color Vision; Disease Models, Animal; Down-Regulation; GABA Antagonists; GABAergic Neurons; gamma-Aminobutyric Acid; Glaucoma; Glutamate Decarboxylase; Inhibitory Postsynaptic Potentials; Kinetics; Male; Models, Biological; Neuroprotective Agents; Ocular Hypertension; Presynaptic Terminals; Pyridazines; Rats, Wistar; Retinal Ganglion Cells | 2017 |